دورية أكاديمية

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

التفاصيل البيبلوغرافية
العنوان: Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
المؤلفون: Powles, Thomas, Kockx, Mark, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J., Van Der Heijden, Michiel S., Szabados, Bernadett, Pous, Albert Font, Gravis, Gwenaelle, Herranz, Urbano Anido, Protheroe, Andrew, Ravaud, Alain, Maillet, Denis, Mendez, Maria Jose, Suarez, Cristina, Linch, Mark, Prendergast, Aaron, van Dam, Pieter-Jan, Stanoeva, Diana, Daelemans, Sofie, Mariathasan, Sanjeev, Tea, Joy S., Mousa, Kelly, Banchereau, Romain, Castellano, Daniel
المساهمون: Roche, The CECM received additional core funding by the UK Experimental Cancer Medicine Network. Mr Jonathan Bull and Mr Michael Jacobson also provided financial support for aspects of the biomarker analysis
المصدر: Nature Medicine ; volume 26, issue 6, page 983-983 ; ISSN 1078-8956 1546-170X
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2020
مصطلحات موضوعية: General Biochemistry, Genetics and Molecular Biology, General Medicine
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41591-020-0923-3
الإتاحة: https://doi.org/10.1038/s41591-020-0923-3Test
http://www.nature.com/articles/s41591-020-0923-3.pdfTest
http://www.nature.com/articles/s41591-020-0923-3Test
حقوق: https://www.springer.com/tdmTest ; https://www.springer.com/tdmTest
رقم الانضمام: edsbas.46168B17
قاعدة البيانات: BASE